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cblFMRP is an RNA binding protein linked to the most common form of inherited mental retardation, Fragile X
syndrome (FraX). In addition to severe cognitive deﬁcits, FraX etiology includes postpubescent
macroorchidism, which is thought to result from overproliferation. Using a Drosophila FraX model, we show
that FMRP controls germline proliferation during oogenesis. dFmr1 null ovaries contain egg chambers with
both fewer and supranumerary germ cells. The mutant germaria contain a signiﬁcantly increased number of
cyclin E and PhosphoHistone H3 positive cells, suggesting that loss of FMRP leads to defects in cell cycle
progression. BrdU incorporation and ﬂow cytometry data suggest that, in addition to proliferation, germline
endoreplication and ploidy are also affected by the loss of FMRP during ovary development. Here we report
that FMRP controls the levels of cbl mRNA in the ovary and that reducing cbl gene dosage by half rescues the
dFmr1 oogenesis phenotypes. These data support a model whereby FMRP controls germline proliferation by
regulating the expression of cbl in the developing ovary.© 2009 Elsevier Inc. All rights reserved.Introduction
Fragile X syndrome is the most common form of inherited mental
retardation and is due to loss of function mutations in the FMR1 gene.
FMR1 encodes an RNA binding protein (FMRP) with demonstrated
roles in both mRNA transport and translation during neural and
synaptic development in both mammals and ﬂies (Dictenberg et al.,
2008; Estes et al., 2008). Despite its ubiquitous expression and the
presence of non-neuronal phenotypes, FMRP function remains under-
studied outside of neural and synaptic development. Such studies are
critical for elucidating the complexities of FMRP biology and could
provide unexpected insights that may prove relevant to the role of
FMRP in the developing nervous system.
The macroorchidism (enlarged testes) associated with Fragile X
syndrome has been attributed to an increased rate of Sertoli cells
proliferation in the developing testes (Slegtenhorst-Eegdeman et al.,
1998). FMRP has recently been shown to cooperate with the miRNA
pathway to control germ stem cell differentiation in the Drosophila
ovary (Yang et al., 2007). An additional role in the germline includes
proper formation of egg chambers during Drosophila oogenesis (Costa
et al., 2005). These studies support a scenario in which FMRP controls
gametogenesis by regulating the translation of speciﬁc mRNA targets,
either through CPEB (Cytoplasmic Polyadenylation Element Binding
protein) or the miRNA pathway.rnescu).
l rights reserved.While many mRNA targets have been predicted through biochem-
ical approaches (Brown et al., 2001; Miyashiro et al., 2003; Zarnescu et
al., 2005), only a handful have been shown to be physiologically
signiﬁcant and mediate certain aspects of FMRP. Such examples
include the Drosophila CPEB homolog, orb (oo18 RNA binding), which
has been shown to control aspects of cyst formation in developing
ovaries (Costa et al., 2005), pickpocket (ppk), which mediates the role
of FMRP in locomotion and sensorial perception (Xu et al., 2004) as
well as proﬁlin and futsch, two major regulators of the actin and
microtubule cytoskeletons, respectively (Reeve et al., 2005; Zhang
et al., 2001). Determining which mRNAs mediate which of the myriad
aspects of FMRP functions throughout development remains a major
challenge in the ﬁeld.
Here we show that FMRP regulates cbl mRNA and this is required
for proper germ cell proliferation in Drosophila ovaries. Phenotypic
analyses of dFmr1 mutant ovaries show the presence of aberrant egg
chambers containing both fewer and supranumerary germ cells. These
data are consistent with both under- and over-proliferation scenarios,
which are further supported by the distribution of various cell cycle
markers including cyclin E, PhosphoHistone H3 and BrdU incorpora-
tion. The loss of dFmr1 also leads to ploidy defects in nurse cells but
not in follicle cells, suggesting that FMRP's control of endocycles is
speciﬁc to the germline and not to the soma during oogenesis. Finally,
a signiﬁcant number of dFmr1 egg chambers exhibit proliferation
defects that are rescued by reducing cbl dosage in the ovary. This
genetic rescue is explained by the presence of higher cbl levels in
dFmr1 ovaries and suggests a mechanism whereby cbl mediates the
84 A.M. Epstein et al. / Developmental Biology 330 (2009) 83–92function of FMRP in controlling germline proliferation during
oogenesis.
Materials and methods
Genetics and ﬂy stocks
Fly stocks were raised on standard cornmeal/yeast/molasses/agar
medium at 25 °C. The dFmr1 alleles used are as follows: w;; dFmr13/
TM6C Tb Sb (obtained from Tom Jongens, University of Pennsylvania)
and w;; dFmr150M/TM6B Tb Hu was obtained from Kendal Broadie
(Vanderbilt University). The recombinant stock w;; cblF165dFmr13/
TM6C Tb Sbwas derived from w;; dFmr13/TM6C Tb Sb and w;; cblF165/
TM3 Ser e (kindly provided by Trudi Schupach, Princeton University)
using meiotic recombination in females. P{SUPor-P}CblKG03080 ry506/
TM3 Sb1 Ser1 was obtained from Bloomington. To generate somatic
clones in adult ovaries the following stocks were used: w1118 P{hsFLP}
22, P{neoFRT}82B P{Ubi-GFP}83/TM3 Ser Sb, (Bloomington Stock
Center), w1118;; FRT82B dFmr150M/TM6B Tb Hu act:GFP and w;;
FRT82B dFmr13/TM6B Tb Hu act:GFP (provided by Kendal Broadie,
Vanderbilt University). Third instar larvae were subjected to a one-
hour heat-shock at 37 °C followed by a second heat-shock in the mid-
pupal stage.Mosaic ovarieswere examined fromadult females ranging
in age from 2, 3, 5 and 7 days after eclosion.
Antibodies
For PhosphoHistone H3 we used rabbit polyclonal anti-PH3
(Millipore) serum at a dilution of 1/500 (Hendzel et al., 1997). BrdU
was detected using a monoclonal antibody against BrdU at 1/20 (BD
Bioscience) (Gratzner, 1982). Cbl-S and Cbl-L were detected simulta-
neously using mouse monoclonal 10F1 at a dilution of 1/500 for
Western blotting (Pai et al., 2006). To detect Cbl-L only we used the
mousemonoclonal 8C4 at 1/100 (anti-Cbl antibodies were a generous
gift from Li Mei Pai, Chang-Gung University, Taiwan). Cyclin E was
detected using guinea pig anti-cyclin E serum at a dilution of 1/500
(G. Bosco and T. Orr-Weaver, unpublished data). Filamentous actin
was visualized with Rhodamine Phalloidin at 1/200 (Molecular
Probes) and nuclear DNA was labeled with DAPI (1 μg/ml, Sigma-
Aldrich). To detect Lgl protein, we used a rabbit polyclonal as
previously described (Zarnescu et al., 2005).
Secondary antibodies used were goat anti-mouse, rabbit or guinea
pig IgG, afﬁnity puriﬁed and coupled to the FITC, Alexa 568, 594 or 633
ﬂuorophores. These antibodies were obtained from Molecular Probes,
rehydrated according to the manufacturer's instructions and used in
conjunction with the appropriate primary antibodies at 1/1000 (1/
250 for FITC goat anti-guinea pig).
Immunohistochemistry
Adult females were collected within 1 day of eclosion, and then
fattened on yeast paste in the presence of males, for 2–4 days before
dissection. Ovaries were dissected in PBS (or in Grace's medium for
BrdU incorporation), ﬁxed for 20 min in 4% formaldehyde (Ted Pella,
Inc.), then washed for 30 min in PBS, 20 min in PBT (PBS with 0.3%
Triton X-100), then blocked for 30 min in PBT supplemented with 10%
normal goat serum (blocking solution). Next, ovaries were incubated
with primary antibodies at 4 °C overnight, followed by washes in PBT,
block solution and secondary antibody incubation for 2–3 h at room
temperature. DAPI was added for 10 min, followed by another PBT
wash, then ovaries were mounted in Vectashield (Vector Labs). For
detection of BrdU incorporation, females were fattened and dissected
as described, then incubated for 3 h at room temp in 30 μg/ml BrdU
(Sigma-Aldrich), freshly prepared in Grace's medium. Following three
rinses in fresh Grace's, ovaries were subjected to several treatment
steps, as previously described (Calvi et al., 1998).In situ hybridizations
Fluorescent in situ hybridization (FISH) experiments were per-
formed essentially as previously described (Lecuyer et al., 2007). In
brief, PCR products were generated from a cbl-S cDNA template
(generously provided by Li Mei Pai, Chang-Gung University, Taiwan).
T7 and SP6 promoter sequences were added at the ends to generate
the following primers: T7cbl-S-5′ GCATCATCTAATACGACTCACTA-
TAGGGCTATACCTCAGTGTCG 3′ (anti-sense) and SP6cbl-S-5′ CATCGT-
CATTTAGGTGACACTATAGAATGGCGACGAGAGGCAGTG 3′ (sense).
Sense and anti-sense cbl-S RNA probes were prepared using DIG
labeling protocols (Roche). Hybridizations were performed at 55 °C
overnight and were followed by immuno-ﬂuorescent detection of DIG
(sheep anti-DIG Rhodamine at 1/200; Roche) in conjunction with
DAPI stainings.
Image acquisition
Fluorescently stained ovaries were imaged using a Zeiss Axiovert
200 (inverted) 510 LSM META confocal microscope (Carl Zeiss Inc.).
Phenotypic datawas collected using a Nikon E800 (Nikon Instruments
Inc.) with standard ﬁlters for DAPI, FITC and Cy3. Image capture was
via an RT Monochrome Spot camera (Diagnostic Instruments Inc.
Model #2.1.1) mounted to the microscope and connected to a G5
Apple Computer running the Spot image capture program (Diagnostic
Instruments Inc.).
Semi-quantitative PCR
RNA was prepared from ovaries isolated from age-matched, sibling
dFmr13 and P[dFmr1+]; dFmr13 females using the mirVana kit (Ambion).
First strand cDNA synthesis was performed using oligo-dT and Omniscript
reverse transcriptase from Qiagen. Serial dilutions of cDNA were PCR
ampliﬁed using primers speciﬁc for cbl-L and cbl-SmRNA. Sequences used
were: cbl-L forward: 5′ TTGGATGAGGACATCGTTGA 3′, cbl-L reverse: 5′
ATAGAGCAGTGGCTGCGATT 3′, cbl-S forward 5′ GCAGTGGCAGTTTC-
GAGTTT 3′ and cbl-S reverse 5′ CAGAGGAAGCGATAGCCAAC 3′. The
resultingPCRproductswereelectrophoresedandvisualizedwithethidium
bromide in agarose gels. Those products in the linear range were imaged
and quantiﬁed using ImageQuant v5.2 software. The average background
ﬂuorescence was subtracted and the signal for each gene was normalized
to the gpdh housekeeping gene (gpdh forward: 5′ CCATGGTTAAAACAA-
TACCAGGATGTACTG 3′ and gpdh reverse: 5′ GATAGCGATGGCATTTGGCT-
TAA3′). Three biological replicateswith two technical replicates eachwere
performed for eachmRNA. P values were calculated using Student's T-test.
Quantitative western blotting
Ovaries were dissected frommutant and control females, manually
homogenized with a pestle in 50 μl of 2X Laemmli Buffer, boiled for
5 min then brieﬂy spun at maximum speed in a microfuge. SDS-PAGE
was performed according to the manufacturer's instructions using a
BioRad apparatus. Following protein transfer, the membrane (Immo-
bilon-P, Millipore) was placed in blocking solution for 30 min (1X PBS,
0.1% Triton X-100, 5% milk), probed with anti-Cbl monoclonal
antibody 10F1 at 1/500 (Pai et al., 2006), followed by several washes
in PBT (1X PBS, 0.1% Triton X-100) and incubation with goat anti-
mouse HRP secondary antibody (Pierce) at 1/1000. Following
additional washes in PBT, the signal was detected using the Alpha
Innotech imaging system (Alpha Innotech) to avoid saturation. Next,
the membrane was stripped (.2 M NaOH for 20 min) and reprobed
with a mouse anti-beta tubulin antibody at 1/2000. Cbl S and Cbl L
were normalized to tubulin protein levels, whichwere quantiﬁed from
three biological replicates using the histogram feature from Adobe
Photoshop 7.0 (Adobe). Note that Cbl-S is expressed at much higher
levels than Cbl-L; therefore two different exposures were taken to
85A.M. Epstein et al. / Developmental Biology 330 (2009) 83–92obtain unsaturated signals. Thus the values shown in Fig. 5B do not
reﬂect the relative ratio between Cbl-L and Cbl-S expression in the
ovaries.
Flow cytometry
To detect the DNA content of germ cells, female ﬂies were fattened
on wet yeast paste in the presence of males for 2–4 days before
dissection. Between 10 and 20 ovaries per genotype were dissected in
Grace's insect cell culture medium (GIBCO). After removal of Grace's,
50 μl of ﬁltered ice-cold Partec Buffer (200mM Tris–HCl, pH 7.5, 4 mM
MgCl2, 0.1% Triton X-100 and ddH20) was added to the ovaries. The
samples were transferred to a 60-mm Petri dish with a pipette tip, and
then chopped with a single-edged razor blade until homogenous. An
additional 500 μl of Partec Buffer was added and ovaries were chopped
again. The samples were then ﬁltered through a 30 μm mesh (Sefar)
and placed into ﬂow cytometry tubes (Sarstedt). After adding DAPI
(100 μg/ml), samples were kept on ice for 60 min before analysis on a
BD FACS Aria high-speed cell sorter (BD BioSciences). Histograms
were obtained for polyploid follicle cells (2c–16c) and for polyploid
nurse cells (32c–512c). The mean ﬂuorescence intensity was obtained
for each peak (2c–512c). To account for variations in sample size, the
fraction of nuclei found in each ploidy class was calculated by dividing
the individual peak mean ﬂuorescence intensity to the total
ﬂuorescence (see Table 2).Fig.1. Loss of dFmr1 in the ovary results in aberrant egg chambers, with both fewer and supra
contains the germarium at the anterior (as labeled) followed by several egg chambers in se
consists of 16 germ cells, including 15 nurse cells (NCs) and one, posteriorly located, oocyte
showing an egg chamber with fewer than 16 germ cells surrounded bymorphologically norm
Arrowhead points to an anteriorly located oocyte nucleus in an otherwise normal egg chamb
shown represent single confocal sections. (D) Quantiﬁcation of egg chambers containing less
cysts in dFmr13 and dFmr13/dFmr150M compared to their rescue controls (averages and genot
1). P values were calculated using Fisher's exact test. Scale bars in (A) −50 μm, (B) −30 μmResults
FMRP controls proper egg chamber formation during oogenesis in
Drosophila
Drosophila ovaries are comprised of 12–16 ovarioles, each contain-
ing an anterior structure called the germarium, followed by a series of
egg chambers that develop in a well-characterized sequence, until
reaching stage 14, which corresponds to a fully mature oocyte, ready
for fertilization (Spradling et al., 1997). Egg chambers emerge from the
posterior region of the germarium as individual 16 germ cell cysts that
are enveloped by a monolayer of somatic follicle cells. Each 16 germ
cell cyst arises through 4 synchronous divisions of an individual
cystoblast and consists of 15 nurse cells, which provide nourishment
to the 16th germ cell, the developing oocyte. Thus oogenesis is an
established system for studies of proliferation, differentiation and
cellular signaling during development. Previous phenotypic analyses
of dFmr13 ovaries have shown that FMRP is required for egg chamber
formation during oogenesis (Costa et al., 2005). To further character-
ize the role of FMRP in the ovary and in oocyte development, we
examined two different allelic combinations of dFmr1mutant ovaries
and found egg chambers with both decreased and increased numbers
of germ cells per chamber (Fig. 1 and Table 1). To minimize genetic
background effects, all mutant phenotypes were analyzed by
comparison to a genomic rescue line (Dockendorff et al., 2002). Wenumerary germ cells. (A) Control ovariole stained with DAPI for visualizing nuclear DNA,
quence. A different ovariole is shown below, within the same frame. Each egg chamber
, surrounded by a monolayer of somatic follicle cells (FCs). (B) dFmr13 mutant ovariole
al cysts. Arrow points to a nurse cell with a signiﬁcantly increased nucleus for its stage.
er. (C) dFmr13mutant egg chamber showing an increased number of germ cells. Images
ormore than 16 germ cells shows a statistically signiﬁcant increased number of aberrant
ypes as shown). Asterisks indicate high statistical signiﬁcance (for all P values, see Table
and (C) −30 μm.
Table 1
Distribution of aberrant egg chambers.
Genotype Egg chambers with b16 germ cells Egg chambers with N16 germ cells Overall aberrant egg chambers
dFmr13 4.4% N=31 5.2% N=37 9.6% Ntotal=705
P[dFmr1+]; dFmr13 0% N=0, P=7×10−10 1% N=7, P=4×10−6 1% Ntotal=684, P=4×10−14
dFmr13/dFmr150M 9.4% N=107 3.4% N=39 12.8% Ntotal=1133
P[dFmr1+]; dFmr13/dFmr150M 0.6% N=2, P=5×10−19 0.9% N=3, P=0.01 1.5% Ntotal=327, P=5×10−12
cblF165 dFmr13/dFmr13 0% N=0, P=4×10−9 2.2% N=13, P=0.002 2.2% Ntotal=627, P=3×10−9
cblF165 dFmr13/dFmr150M 1.8% N=12, P=2×10−11 5% N=33, P=0.1 6.8% Ntotal=655, P=5×10−5
Loss of dFmr1 leads to the formation of egg chambers with fewer and supranumerary germ cells. This defect is restored by the genomic rescue construct P[dFmr1+] and loss of cbl as
shown. P values were calculated using Fisher's exact test.
86 A.M. Epstein et al. / Developmental Biology 330 (2009) 83–92found that dFmr13 ovaries contained 4.4% egg chambers with less than
16 germ cells (N=705) with an average of 8.2 germ cells per cyst
(N=31). 5.2% of the egg chambers in dFmr13 ovaries had more than
16 germ cells (N=705), with an average of 34.9 germ cells per cyst
(N=37). Although a small number of bicephalic cysts were observed
(b0.1%, NNN1000, data not shown) the enlarged egg chambers
generally contained a single oocyte, suggesting that by and large,
oocyte speciﬁcation occurs normally in dFmr1 ovaries (see also Costa
et al., 2005). In contrast, the control ovaries (P[dFmr1+]; dFmr13)
contained no egg chambers with fewer than 16 germ cells (N=684)
and only 1% egg chambers with more than 16 germ cells (N=684)Fig. 2. Loss of dFmr1 leads to germ cell proliferation defects during oogenesis. (A–D) Cyclin E
expression for the G1/S transitionmarker in a few germ cells within zone 1 (arrowhead), low
contrast, dFmr13 germaria contain signiﬁcantlymore cells expressingmoderate to high levels
3 (C, D). On average, dFmr13 germaria contain signiﬁcantly more cyclin E positive cells (see al
which stains all nuclei within the shown germaria. (E–G) PhosphoHistone H3 immunolabel
germaria (G, H). (F) and (H) are merged images of (E) and (G), respectively with DAPI to sh
contain signiﬁcantly more mitotic cells (see also panel J). Images shown represent projectio
Quantiﬁcation shows a statistically signiﬁcant increase of cyclin E positive cells in dFmr1 germ
in dFmr13 homozygous (N=26) and 21.9+/−0.8 in dFmr13/dFmr150M (N=30) germaria
germaria, P=1.3×10−19) in their respective controls. (J) Quantiﬁcation shows a statisticall
average, 9.4+/−0.6 PH3 positive cells were present in dFmr13 homozygous (N=25) and
germaria, P=5.3×10−20) and 3.1+/−0.4 (N=19 germaria, P=2.6×10−7) in their respec
statistical signiﬁcance. Scale bar in (A) −30 μm.containing on average 29.3 nurse cells per chamber (Fig. 1). dFmr13/
dFmr150M ovaries contained similar phenotypes as the homozygotes
when compared to controls (see Table 1 and Fig. 1D).
These aberrant egg chambers were generally surrounded by
normal ones, suggesting that the chamber formation defect is cyst-
autonomous and is due to defects in germline proliferation within
each cyst, rather than due to abnormal envelopment by follicle cells
upon exit from the germarium. Surprisingly, these aberrant egg
chambers were not detected when the Df(3R)6265 was used in
combination with the either dFmr13 or dFmr150M. Since both alleles
used here are deletions within the dFmr1 locus and by Westernimmunolocalization in P[dFmr1+];dFmr13 control germaria (A, B) shows high levels of
to no expression in Zone 2 andmoderate expression in Zone 3 (stage 1 egg chamber). In
of cyclin E in both Zones 1 (arrowhead) and 2 (asterisk) and slightly less cyclin E in Zone
so panel I). (B) and (D) represent merged images of (A) and (C), respectively with DAPI,
ing shows fewer mitotic cells in P[dFmr1+];dFmr13 controls (E, F) compared to dFmr13
ow all nuclei. Dashed lines represent germaria contours. On average, dFmr13 germaria
ns of 1 μm thick confocal sections spanning the thickness of the individual germaria. (I)
aria compared to controls. On average, 25.5+/−1.2 cyclin E positive cells were present
compared to 10.2+/−0.8 (N=26 germaria, P=1.2×10−14) and 8.2+/−0.6 (N=30
y signiﬁcant increase of PH3 positive cells in dFmr1 germaria compared to controls. On
7.5+/−0.6 in dFmr13/dFmr150M (N=20) germaria compared to 2.4+/−0.3 (N=30
tive controls. P values were calculated using the Student's T-test. Asterisks indicate high
87A.M. Epstein et al. / Developmental Biology 330 (2009) 83–92analysis, produce no detectable FMRP in the ovary (data not shown,
see also Dockendorff et al., 2002; Zhang et al., 2001), our results
suggest that the Df(3R)6265 deﬁciency line contains a suppressor of
the null ovarian phenotype. Given that two different alleles produce
similar phenotypes that are rescued by reintroducing dFmr1 in its
genomic context, we conclude that the loss of FMRP in the ovary is the
sole source of the germline proliferation defects observed.
Loss of dFmr1 leads to cyclin E upregulation in the ovary
A possible explanation for the presence of both fewer and
supranumerary germ cells (Fig. 1) is a defect in proliferation. 16 cell
cysts form in the germarium where a germ stem cell divides
asymmetrically to give rise to another stem cell and a cystoblast
(Zone 1, Fig. 2). The cystoblast divides synchronously four times, with
incomplete cytokinesis, such that the end result is a 16-cell cyst (Zone
2, Fig. 2), which emerges at the posterior end of the germarium as a
stage 1 egg chamber. To investigate the possibility that FMRP controls
proliferation in the germarium, we began by surveying the distribu-
tion of cyclin E, a key regulator of the G1-S transition, throughout the
dFmr1 mutant and control ovaries. Indeed, the dFmr13 mutant
germaria contained on average signiﬁcantly more cyclin E positive
cells than P[dFmr1+]; dFmr13 germaria within Zones 1 and 2, where
cysts are actively proliferating (Figs. 2A–D, I). No major differences
were detected in cyclin E staining throughout the rest of the dFmr13
ovaries when compared to the rescue controls (P[dFmr1+]; dFmr13).
These data suggest two possibilities: i) that more germ cells lackingFig. 3. dFmr1mutant nurse cells incorporate more BrdU throughout oogenesis and exhibit en
(A, B), stages 2–9 (E, F) and stage 10 egg chambers (I, J) compared to dFmr13 mutant germar
show all nuclei (see merged panels B, D, F, H, J and L). Mutant ovaries contain more egg cham
well as more germ cells per cyst that are BrdU positive (compare arrows in A to C, E to G and a
cells shows that 84% of mutant germaria (N=94) incorporate BrdU compared to 67% in cont
mutant egg chambers (N=35) incorporate BrdU compared to only 12% stages 2–9 (N=436
were calculated using Fisher's exact test. Asterisks indicate high statistical signiﬁcance. (N, O)
control (P[dFmr1+];dFmr13) and dFmr13 mutant ovaries show endocycle defects in the g
signiﬁcant differences between genotypes. (O) Overlay of control (black) andmutant (red) N
controls (see Table 2 for quantiﬁcation). For clarity, the low ploidy peaks (2c–16c) which conFMRP progress through the cell cycle, which is consistent with
overproliferation of the germline, or ii) that dFmr1mutant germ cells
are delayed at the G1-S transition in the germaria, which supports an
underproliferation scenario. Given the presence of egg chambers with
both fewer and supranumerary germ cells, it is likely that both over-
and under-proliferation are occurring in the absence of FMRP
function, possibly through misregulation of distinct mRNAs.
FMRP controls germ cell proliferation in the germarium
To conﬁrm that FMRP controls cellular proliferation during
oogenesis, we examined the distribution of the mitotic marker,
PhosphoHistone H3 (PH3) in the dFmr1 mutant and control ovaries.
As shown in Figs. 2E–H and J, the dFmr1 germaria contained
signiﬁcantly more PH3 positive germ cells than controls. No mitotic
germ cells were observed posterior to the germarium, which is
consistent with the notion that the source of proliferation defects
lies within the germarium. On average, dFmr13 ovaries contained 9.4
PH3 positive cells per germarium compared to only 2.4 found in
controls (P[dFmr1+]; dFmr13). Similar results were obtained for the
dFmr13/dFmr150M ovaries, which contained on average 7.5 PH3
positive cells per germarium compared to 3.1 in controls (P[dFmr1+];
dFmr13/dFmr150M). Thus the loss of dFmr1 leads to an increased
number of mitotic cells which is consistent with a defect in germ
cell proliferation, whereby either more mutant cells proliferate or
are “stuck” in the M phase. These ﬁndings support the cyclin E data
and explain the presence of both supranumerary (overproliferation)docycle defects during previtellogenesis. (A–M) BrdU incorporation in control germaria
ia (C, D), stages 2–9 (G, H) and stage 10 egg chambers (K, L). DAPI staining was used to
bers that incorporate BrdU compared to controls (see also panel M for quantiﬁcation) as
rrowheads in I to K). (M) Quantiﬁcation of egg chambers containing BrdU positive germ
rol ovaries (N=137, P=0.006). Similarly, 36% of stages 2–9 (N=229) and 71% stage 10
, P=6×10−13) and 23% stage 10 control egg chambers (N=71, P=1×10−6). P values
Flow cytometry analysis of follicle cells (FC, see N) and nurse cells (NC, see O) ploidy in
ermline. (N) Overlay of control (black) and mutant (red) FC ploidy proﬁles show no
C proﬁles shows endocycle defects with decreased DNA content peaks inmutants versus
tain mostly follicle cells have been removed from the NC plots. Genotypes are as shown.
Table 2
Nurse cells ploidy distribution for dFmr13 and control ovaries.
Genotype 32c 64c 128c 256c 512c
P[dFmr1+]; dFmr13 9.2% 17.6% 19.5% 21.1% 9.1%
dFmr13 8.6% 22.4% 20.5% 18.2% 6.5%
Loss of dFmr1 leads to fewer nurse cells with high ploidy (N128c) compared to controls.
To account for the different number of total nuclei derived from each genotype we
calculated the percentage of nurse cell nuclei with 32c, 64c, 128c, 256c and 512c ploidy
out of the total number of nuclei detected.
Fig. 4. cbl is a dominant suppressor of the proliferation defects due to loss of dFmr1. (A)
Loss of cbl rescues the aberrant egg chamber phenotype exhibited by dFmr1 ovaries.
Quantiﬁcation of the proliferation phenotype shows that dFmr13 ovaries exhibit 9.6%
aberrant egg chambers (including ones with fewer and supranumerary germ cells,
N=705) compared to only 2.2% when cbl dosage is reduced by half (cblF165 dFmr13/
dFmr13, N=627, P=1×10−8, see also Table 1). Similarly, dFmr13/dFmr150M ovaries
exhibit on average, 12.8% aberrant egg chambers (N=1133) compared to 6.8% when cbl
dosage is reduced by half (cblF165 dFmr13/dFmr150M, N=655, P=0.003). cblF165/+
ovaries exhibited no aberrant egg chambers (N=315). Note that the fewer germ cell
phenotypes (underproliferation) are signiﬁcantly rescued while the supranumerary
germ cell phenotype (overproliferation) is partially rescued or unchanged, depending
on the allelic combination (see Table 1). (B) Mutations in cbl rescue the cyclin E
overexpression found in dFmr1 ovaries. Quantiﬁcation shows that reducing cbl dosage
by half (cblF165 dFmr13/dFmr13) results in an average of 6.75+/−0.5 cyclin E positive
cells per germarium (N=24, P=1.5×10−18) compared to 25.5+/−1.2 cyclin E
positive cells found in dFmr13 homozygous (N=26) and 10.2+/−0.8 (N=26
germaria, P=1.2×10−14) in control (P[dFmr1+];dFmr13) germaria. Asterisks indicate
P valuesbbb0.001.
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(Fig. 1).
Loss of dFmr1 results in S phase defects throughout oogenesis
To further test the role of FMRP in germline proliferation, we
compared the levels of BrdU incorporation in dFmr13 and rescue (P
[dFmr1+]; dFmr13) germaria. Indeed, more dFmr1 mutant germaria
were BrdU positive compared to controls (84% versus 67%, P
value=0.0001, N=137 mutant and 94 control germaria; see Figs.
3A–D andM). These ﬁndings support the notion that the loss of dFmr1
loss leads to germline overproliferation and provides an explanation
for the presence of supranumerary egg chambers found in the mutant
ovaries.
Following the formation of the 16 cell cysts and upon exiting the
germarium, the 15 nurse cells initiate endocycles and become
polyploid. During this time, the nurse cells undergo a modiﬁed cell
cycle, which alternates between the G and S phases only (Dej and
Spradling,1999). Since the endocycle is controlled by similar factors as
the canonical cell cycle (Lilly and Spradling, 1996) and given the
cycling defects seen in dFmr1 ovaries (Fig. 2), we asked whether FMRP
may also control progression through S phase subsequent to germline
divisions. To this end, we examined the pattern of BrdU incorporation
in dFmr13 ovaries compared to controls (P[dFmr1+]; dFmr13) and
found a signiﬁcantly increased amount of BrdU positive egg chambers
posterior to the germarium (Fig. 3). We scored the egg chambers that
had little to no BrdU signal as negative for BrdU incorporation and
found that 36% of egg chambers between stages 2 and 9 (previtello-
genesis) were BrdU positive in dFmr13 ovaries compared to 12% in
controls (P[dFmr1+]; dFmr13) (see Figs. 3E–H and M). Similarly, 71%
of stage 10 egg chambers were BrdU positive in dFmr13 ovaries
compared to 23% in controls (P[dFmr1+]; dFmr13) (see Figs. 3I–L and
M). Given that no mitotic germ cells were detected posterior to the
germarium and the pattern of BrdU incorporation, we conclude that
the loss of dFmr1 leads to either a delay in the S phase of the endocycle
or additional endoreplication cycles. To test these possibilities, we
isolated nurse and follicle cell nuclei and examined their cell cycle
proﬁle using ﬂow cytometry (Figs. 3N, O). As expected, control follicle
and nurse cells (P[dFmr1+]; dFmr13) are polyploid, with a DNA
content ranging from 2c to 16c and 32c to 512c, respectively (Figs. 3N,
O) (Dej and Spradling, 1999). No obvious defects were observed for
the dFmr13 follicle cells, where both ploidy (Fig. 3N) and the onset of
chorion gene ampliﬁcation (as indicated by BrdU incorporation)
appeared normal, consistent with the notion that FMRP controls the
endocycle in the germline but not the soma. Indeed, dFmr13 nurse
cells exhibit decreased 256c and 512c peaks (Fig. 3O and Table 2),
indicating that the loss of FMRP leads to a misregulation of the
endocycle and under-representation of higher ploidy nurse cells. Note
that the difference in the number of higher ploidy nurse cells is not
due to different amounts of total nuclei analyzed for the mutant and
the wild-type controls because the fractions of nuclei with 512c and
256c show speciﬁc depletion of these ploidy classes in themutant (see
Table 2). Thus, comparison of the control andmutant cell cycle proﬁles
suggest that the dFmr1 nurse cells may progress at a slower pace
through cycles 7 and 8 (256c and 512c).Loss of cbl rescues the aberrant egg chamber phenotype and restores
cyclin E expression in dFmr1 ovaries
A critical step in elucidating the molecular mechanisms of FMRP
throughout development is identifying the mRNAs that mediate its
function in speciﬁc tissues. Using a combination of whole ﬂy
immunoprecipitations followed by microarray experiments, we have
previously identiﬁed a number of mRNAs physically associated with
FMRP in Drosophila (Zarnescu et al., 2005). Among these candidate
mRNA targets is cbl, which encodes an E3 ubiquitin ligase previously
demonstrated to be required during oogenesis (Pai et al., 2000).
These results suggest that cbl may mediate some functional aspects
of FMRP during development, a prediction that we tested using
genetic interaction experiments. Indeed, by reducing the cbl gene
dosage in half, dFmr13 ovaries show a reduction of the overall
aberrant egg chamber phenotype from 9.6% (N=705) to 2.2%
(N=627, P=1×10−8; see Fig. 4A and Table 1). Interestingly, the
fewer germ cell phenotype was completely rescued (from 4.4% in
mutant ovaries to 0% when cbl dosage was reduced in a dFmr13
background, P=4×10−9) while the supranumerary germ cell
phenotype was reduced (from 5.2% in mutant ovaries to 2.2% when
cbl dosage was reduced in a dFmr13 background, P=0.003).
dFmr150M/cbl F165dFmr13 ovaries also showed a reduction in the
overall number of aberrant egg chambers from 12.8% (N=1133) to
6.8% in dFmr150M/dFmr13 ovaries (N=655, P=3×10−4). However,
while the fewer germ cell phenotype was rescued by reducing cbl
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a dFmr150M/dFmr13 background, P=2×10−10), the supranumerary
germ cell phenotype was slightly increased, albeit not in a
statistically signiﬁcant manner (from 3.4% in mutant ovaries to
5.0% when cbl dosage was reduced in a dFmr150M/dFmr13 back-
ground, P=0.13). We also examined the cblF165 heterozygous ovaries
(cblF165/+) and found no egg chamber abnormalities (N=315).
Taken together, our data demonstrate that reducing cbl dosage
rescues the underproliferation phenotype while affecting only
slightly the overproliferation phenotype due to the loss of dFmr1.
These results suggest that cbl is a target of FMRP that primarily
mediates its function of promoting germ cell proliferation during
oogenesis.
Next, we tested if reducing cbl function also rescues the abnormal
distribution of cyclin E positive cells in the dFmr1 mutant germaria.Fig. 5. Loss of dFmr1 results in increased levels of cbl mRNA but not Cbl protein in the ovar
signiﬁcant higher levels of both cbl-L and cbl-SmRNA in developing ovaries compared to con
(P[dFmr1+];dFmr13) to 1.03+/−0.09 in dFmr13 ovaries (P=0.04), while cbl-S mRNA incr
ovaries (P=1×10−5). Three biological replicates were performed. Asterisks indicate statisti
and Cbl-S levels between control (P[dFmr1+];dFmr13) and dFmr13 ovaries. Cbl-L protein lev
ovaries (P=0.4), while Cbl-S protein levels measured 1.1+/−0.2 in controls (P[dFmr1+];d
relative to tubulin. (C–H) In situ hybridization of cbl mRNA reveals a slight upregulation in d
control shown in (C). (D), (F) and (H) represent DAPI stainings of the egg chambers shownIndeed, the average number of cycline E positive cells in cblF165
dFmr13/dFmr13 germaria is reduced to 6.75+/−0.5 (N=24) from
25.5+/−1.2 (N=26, P=1.5×10−8) found in dFmr13 germaria (Fig.
4B). These data suggest that cbl mediates the proliferative function of
FMRP via controlling cyclin E expression in the developing germline.
FMRP controls cbl mRNA levels in the ovary
A prediction from our genetic rescue experiments is that the loss
of FMRP results in an upregulation of cbl expression in the ovary. To
test this, we performed semi-quantitative PCR and found that both
cbl-L and cbl-S mRNAs are upregulated in the dFmr1 mutant ovaries
compared to controls (20%, Fig. 5A). These data are consistent with
our recent ﬁndings, where using genome-wide expression arrays, we
found that cblmRNA is upregulated in dFmr1whole ﬂies compared toy. (A) Semi-quantitative PCR experiments show that loss of dFmr1 leads to statistically
trols. cbl-LmRNA levels (normalized to gapdh) increased from 0.78+/−0.06 in controls
eased from 0.55+/−0.02 in controls (P[dFmr1+];dFmr13) to 0.77+/−0.01 in dFmr13
cal signiﬁcance. (B) Quantitative Western blots show no signiﬁcant differences in Cbl-L
els measured 10.4+/−0.3 in controls (P[dFmr1+];dFmr13) and 10.0+/−1.7 in dFmr13
Fmr13) and 1.2+/−0.1 in dFmr13 ovaries (P=0.6). Cbl protein levels were normalized
Fmr13 ovaries (G, see arrows) compared to controls (P[dFmr1+];dFmr13, see E). Sense
in (C), (E) and (G), respectively.
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experiments did not show a visible increase in cbl mRNA levels in the
dFmr13 ovaries compared to controls, although small foci of increased
ﬂuorescence could be seen around some nurse cell nuclei (arrows,
Figs. 5C–H). Taken together, our results suggest that FMRP controls
cbl mRNA levels, possibly by regulating its transcription and/or
stability.
We also used Western blotting to determine the levels of Cbl
protein in the ovary but found no signiﬁcant changes in mutant
ovaries versus controls (Fig. 5B). Although we cannot exclude the
possibility that excess cbl mRNA leads to mislocalized Cbl protein
synthesis, which cannot be detected by Western blotting, immuno-
localization experiments also failed to detect any obvious upregula-
tion of Cbl protein in the ovaries. In some confocal sections, Cbl
appeared to be locally concentrated in the dFmr1 germline, but this
was not seen consistently (see arrows in Supplemental Fig. 1). At
face value, our results do not support a role for FMRP as a
translational regulator of cbl. Instead, these data suggest that the
loss of FMRP may affect the turnover rate or transcription of cbl
mRNA (see Fig. 6).
FMRP functions in the ovary in a non-autonomous manner
A remaining question is whether FMRP is required for proper
germline division and egg chamber formation in a cell autonomous
manner. To address this issue, we used the ﬂp-FRT system (Xu and
Rubin, 1993) to generate mosaic ovaries containing dFmr1 mutant
egg chambers surrounded by heterozygous follicle cells (see
Materials and methods). While several completely mutant egg
chambers were obtained (NN200), none of them exhibited prolifera-
tion defects and appeared morphologically normal (Supplemental
Fig. 2). These data suggest that FMRP is required non-autonomously
for proper germline proliferation and is consistent with previous
ﬁndings on the role of FMRP in germ stem cell maintenance (Yang et
al., 2007).Fig. 6. Model for FMRP function in germ cell proliferation and proper egg chamber
development in the ovary. In wild-type ovaries, FMRP controls the expression of cbl,
which in turn, mediates FMRP's function in germ cell proliferation. RT-PCR and genetic
rescue experiments suggest that normally, FMRP negatively regulates the expression of
cbl mRNA and this in turn controls the proliferation of the germline. Reduction of cbl
dosage by half rescues signiﬁcantly the dFmr1 underproliferation phenotype but only
partially the overproliferation phenotype, therefore we suggest that the normal role of
cbl is to primarily inhibit germ cell proliferation, although it may act as a positive
regulator of proliferation as well. Expressing just the right levels of cblmRNA is required
for proper egg chamber formation. In the absence of dFmr1, cblmRNA is overexpressed
through a mechanism that remains to be determined. Some possibilities include: i)
misregulation of transcription, possibly due to chromatin disorganization as a
consequence of the endoreplication defects found in nurse cells and ii) increased
mRNA stability, possibly due to alterations in RNA granule composition. It is also
possible that dFmr1 loss leads to cbl mRNA mislocalization and possibly, defects in
localized protein synthesis. As a consequence of high cbl mRNA levels, the germline
suffers proliferation defects, which in turn leads to the formation of aberrant egg
chambers.Discussion
Fragile X protein is an RNA binding protein with demonstrated
roles in mRNA transport, localization, stability and translation
(Dictenberg et al., 2008; Estes et al., 2008; Laggerbauer et al., 2001;
Li et al., 2001; Zalfa et al., 2007). It is currently accepted that FMRP
regulates speciﬁc mRNAs, both directly as well as via the miRNA and
siRNA pathways (Ishizuka et al., 2002; Jin et al., 2004) and it is the
misregulation of these mRNA targets that is thought to lead to the
anatomical and cognitive defects associated with Fragile X syndrome
(FraX) (Dictenberg et al., 2008; Reeve et al., 2005; Wang et al., 2008;
Zhang et al., 2001). Using biochemical puriﬁcation approaches, several
groups have shown that FMRP associates with several mRNA targets
(Brown et al., 2001; Miyashiro et al., 2003; Zarnescu et al., 2005), yet
only a few of these have been demonstrated to mediate some aspect of
FMRP function in vivo (Costa et al., 2005; Lee et al., 2003; Reeve et al.,
2005; Schenck et al., 2003; Xu et al., 2004; Zhang et al., 2001). With
the establishment of the Drosophila FraX model, genetic tools have
become available to test for the physiological signiﬁcance of themRNA
targets predicted through biochemical approaches. The challenge
remains to identify which mRNA targets mediate speciﬁc aspects of
FMRP's function throughout development and also to determine how
they are regulated. Here we report that cbl mRNA, which we
previously found to be associated with FMRP in a complex (Zarnescu
et al., 2005), is overexpressed in dFmr1 mutant ovaries and interacts
genetically with dFmr1. We provide the ﬁrst evidence that FMRP
controls cellular proliferation in the Drosophila germline and that this
is, in part, achieved by controlling cbl mRNA expression.
Fragile X protein plays a role in cellular proliferation
The majority of studies on FMRP biology have focused on its role in
neuronal tissues, largely due to its implication in FraX, a syndrome
characterized by severe cognitive deﬁcits and behavioral abnormal-
ities. Despite its ubiquitous expression throughout development, the
role of FMRP in non-neuronal tissues remains understudied. Recently,
FMRP has been shown to function during embryogenesis in Drosophila
where it is required for cleavage furrow formation, regulation of the
ﬁrst rapid nuclear divisions as well as chromatin organization
(Deshpande et al., 2006; Monzo et al., 2006). Other new functions
outside the nervous system include a requirement for FMRP in proper
egg chamber formation and germ stem cell maintenance during
Drosophila oogenesis (this article and Costa et al., 2005; Yang et al.,
2007). In addition, FMRP has been implicated in the proliferation of
Sertoli cells, which function as support cells for the germline during
testes development (Slegtenhorst-Eegdeman et al., 1998). Another
link to cellular proliferation and differentiation comes from an in vitro
study of neural stem cells, which suggests that FMRP may control
these processes early in the development of the nervous system
(Castren et al., 2005). These studies have not only shed light on the
complexity of developmental roles for RNA binding proteins and their
targets but have also provided valuable insights into FMRP functions
that simply cannot be studied in the post-mitotic neuronal cells.
It has recently been shown that the loss of dFmr1 results in the
formation of an egg chamber with fewer as well as supranumerary
germ cells (see also Fig. 1 here) and this can be rescued in part by
mutations in orb, the Drosophila homolog of the translational
regulator CPEB (Costa et al., 2005). In addition, the loss of dFmr1
leads to premature differentiation and depletion of germ stem cells in
the ovary (Yang et al., 2007). Taken together, both of these studies
raise the possibility that FMRP might control the proliferation of the
germline, which could explain both the presence of egg chambers
with abnormal numbers of germ cells as well as the progressive loss of
stem cells, possibly due to cell cycle defects, which in turn, may lead to
premature differentiation. To test this possibility, we surveyed a
battery of cell cyclemarkers, including cyclin E (G1/S transition), BrdU
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distribution in dFmr1 and control ovaries. Our ﬁndings of additional
cyclin E and PH3 positive cells in mutant germaria (Fig. 2) can be
interpreted in two ways: i) there are more proliferative mutant cells,
or ii) mutant germ cells are delayed as they progress through the cell
cycle. The only way to distinguish between these possibilities is to
count the number of germ cells in the dFmr1 ovaries and determine if
there are more of them, which would support the overproliferation
hypothesis (i), or fewer, which is consistent with a cell cycle delay and
subsequent underproliferation (ii). Given that loss of dFmr1 results in
aberrant egg chambers with both supranumerary and fewer germ
cells, we conclude that FMRP functions both as an inhibitor as well as a
promoter of proliferation in the germline. Such a scenario would
explainwhy sometimes the dFmr1 loss of function phenotypes exhibit
variable expressivity and can be surprisingly mild. Interestingly, the
increased BrdU incorporation supports the overproliferation scenario
and provides an explanation for the presence of supranumerary egg
chambers only. This can occur if dFmr1 mutant germ cells enter S
phase prematurely but suffer a delay in mitosis. An alternative
interpretation, which could also explain the presence of egg chambers
with both more and less than 15 germ cells, is that loss of dFmr1 leads
to asynchronous nuclear divisions, a phenomenon recently observed
in Drosophila dFmr1 syncytia (Deshpande et al., 2006). It is also
formally possible that loss of dFmr1 leads to a failure of mitosis, which
could explain the presence of egg chambers with fewer germ cells.
mRNA targets as mediators of FMRP function throughout development
Although a number of mRNA targets have already been demon-
strated to act as effectors of FMRP, these studies are just beginning to
uncover the complexities of FMRP function during development.
FMRP has been shown to control some aspects of synaptic morphol-
ogy by regulating futschmRNA, which in turn, regulates the stability of
the microtubule cytoskeleton (Wang et al., 2008; Zhang et al., 2001).
Rac1 and proﬁlin mRNAs are both regulated by FMRP and mediate its
function in neuronal morphology and neurite arborization (Lee et al.,
2003; Reeve et al., 2005; Schenck et al., 2003). pickpocket (ppk) mRNA
has been shown to mediate FMRP's function in the sensory input that
controls crawling behavior in Drosophila (Xu et al., 2004) while trailer
hitch (tral) mRNA, has been shown to be regulated by FMRP during the
mid-blastula transition (Monzo et al., 2006).
Our phenotypic analyses of the dFmr1 mutant ovaries suggest
that FMRP functions both to promote and to inhibit germ cell
proliferation. These apparently antagonistic roles for FMRP are likely
to occur by controlling distinct mRNA targets and pathways during
oogenesis. Here we focused on the relationship between FMRP and
cbl mRNA, which we have previously shown to form a complex in
vivo (Zarnescu et al., 2005). Using genetic interaction experiments,
we show that reducing cbl dosage by half results in the rescue of
proliferation defects due to the loss of dFmr1 (Fig. 4). Notably, cbl
rescues mainly the underproliferation phenotype and to a lesser
extent, if at all, the overproliferation phenotype, suggesting that cbl
mediates primarily FMRP's function as a promoter of proliferation
(see Table 1). This is consistent with a previous report showing that
mutations in orb rescue the supranumerary germ cell phenotype of
dFmr1 ovaries (see Table 1 in Costa et al., 2005) and suggests that
orb mainly mediates the function of FMRP as an inhibitor of
proliferation in the ovary.
Our data also show that FMRP acts through cbl to regulate cell cycle
progression, possibly by controlling cyclin E expression in the
germaria (Fig. 4). However, when egg chambers lacking FMRP in the
germline but not in the follicle cells were generated, no obvious
phenotypes were observed (Supplemental Fig. 2). Taken together, the
results from these experiments suggest that FMRP functions non-
autonomously during oogenesis, through its effector, cbl to control the
proper number of cell divisions in the germline. As an interestingparallel, FMRP also appears to act in a non-autonomous manner
during neural development: dFmr1 mutant clones in the mushroom
bodies show arborization defects that are much milder than those
found in whole mutant brains (Michel et al., 2004; Pan et al., 2004).
A prediction from our genetic interaction experiments is that cbl is
upregulated in the absence of dFmr1. Indeed, quantitative RT-PCR
shows that both cbl S and cbl L mRNAs are higher in dFmr1 ovaries
compared to controls (Fig. 5A). Although not quantitative, our in situ
hybridization experiments also show what appears to be a slight
upregulation of cbl mRNA in the germline (arrows in Figs. 5D–H).
Surprisingly, we could not detect a signiﬁcant change in Cbl protein
levels (Fig. 5B) or localization (Supplemental Fig. 1), which argues
against FMRP being a canonical translational regulator of cbl. At face
value, these data suggest that FMRP acts through cblmRNA to regulate
germline proliferation. Perhaps, the loss of FMRP alters the composi-
tion and the physiology of RNA granules and this affects the fate of cbl
mRNA, which in turn leads to the observed phenotypes. It has recently
been shown that the loss of FMRP affects the assembly of stress
granules, which supports the notion that FMRPmay control mRNAs in
ways other than as a negative regulator of translation (Didiot et al.,
2008). We have also recently shown that the loss of FMRP affects the
exchange rate of mRNA molecules between RNA granules and the
cytoplasmic pool (Estes et al., 2008), which could potentially affect
RNA transport, translation and/or stability. Alternatively, given
FMRP's requirement in mRNA transport (Estes et al., 2008), it is
formally possible that cbl mRNA may be aberrantly localized and this
leads to abnormal local translation. Such a scenario would result in
locally altered Cbl protein levels that may be difﬁcult to detect by
Western or immuno-histochemistry.
Taken together, our results show that FMRP controls the produc-
tion and/or stability of cbl mRNA during oogenesis and that
upregulation of cbl levels leads to the observed germline proliferation
defects (see Fig. 6 for model). Interestingly, tral mRNA is upregulated
in dFmr1 null embryos while Tral protein is slightly downregulated
(Monzo et al., 2006). In addition, ppk mRNA, which mediates FMRP's
function in locomotor activity is upregulated in dFmr1 embryos,
possibly through an RNAi mechanism that involves Argonaute 2
(Ago2) (Xu et al., 2004). It will be interesting to see if FMRP also
interacts with Ago2 and the RNAi machinery during oogenesis.
Lessons from non-neuronal tissues
In recent years, a number of reports have begun to explore FMRP's
function outside neuronal tissues. These studies, while they may
appear disconnected from the human disorder, provide valuable
insights into FMRP's functions that simply cannot be studied in the
post-mitotic neuronal cells. For example, it may be that neural stem
cells and progenitors also require FMRP for proper proliferation and
differentiation as the germline does, and one critical function of FMRP
in neurogenesis may be to control cell division in progenitor cells. In
vitro manipulations of FraX neurospheres suggest that this might be
the case althoughmorework is needed to establish the role of FMRP in
early neural development (Castren et al., 2005). Future studies will
aim to determine the requirement of FMRP in the Drosophila brain
neuroblasts and preliminary observations are consistent with a role in
proliferation (Callan and Zarnescu, unpublished observations). Thus
the lessons learned from oogenesis in the ﬂy might prove to be far
reaching and give us new clues towards understanding the role of
FMRP in cognition and behavior.
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